Prestige Consumer Healthcare Inc. (NYSE:PBH) Given Consensus Recommendation of “Hold” by Brokerages

Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) have received a consensus rating of “Hold” from the six ratings firms that are covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company. The average 12-month price target among brokers that have covered the stock in the last year is $70.75.

Several research firms have recently commented on PBH. Oppenheimer lowered Prestige Consumer Healthcare from an “outperform” rating to a “market perform” rating in a report on Thursday, May 14th. Weiss Ratings downgraded Prestige Consumer Healthcare from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Thursday, June 25th. Canaccord Genuity Group decreased their target price on shares of Prestige Consumer Healthcare from $86.00 to $72.00 and set a “buy” rating on the stock in a research report on Friday, May 15th. Finally, Zacks Research upgraded Prestige Consumer Healthcare from a “strong sell” rating to a “hold” rating in a research note on Monday, August 10th.

Prestige Consumer Healthcare Trading Down 1.2%

Shares of PBH stock opened at $51.38 on Wednesday. The stock’s fifty day moving average is $49.90 and its two-hundred day moving average is $54.84. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.99 and a current ratio of 3.23. The firm has a market capitalization of $2.43 billion, a P/E ratio of 14.39, a PEG ratio of 1.63 and a beta of 0.34. Prestige Consumer Healthcare has a fifty-two week low of $42.62 and a fifty-two week high of $71.07.

Prestige Consumer Healthcare (NYSE:PBH) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.98 earnings per share for the quarter, topping analysts’ consensus estimates of $0.89 by $0.09. The firm had revenue of $265.71 million for the quarter, compared to analyst estimates of $253.02 million. Prestige Consumer Healthcare had a net margin of 15.57% and a return on equity of 11.39%. Prestige Consumer Healthcare’s quarterly revenue was up 6.5% on a year-over-year basis. During the same period in the previous year, the business posted $0.90 earnings per share. Prestige Consumer Healthcare has set its FY 2027 guidance at 4.550-4.650 EPS. Research analysts expect that Prestige Consumer Healthcare will post 4.56 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in PBH. California State Teachers Retirement System increased its position in shares of Prestige Consumer Healthcare by 4,490.7% during the second quarter. California State Teachers Retirement System now owns 2,630,954 shares of the company’s stock worth $124,365,000 after acquiring an additional 2,573,644 shares during the period. AXQ Capital LP purchased a new position in shares of Prestige Consumer Healthcare in the 2nd quarter valued at about $572,000. Nykredit A S acquired a new position in shares of Prestige Consumer Healthcare during the second quarter worth about $133,000. Hsbc Holdings PLC acquired a new position in shares of Prestige Consumer Healthcare during the second quarter worth about $508,000. Finally, North Star Asset Management Inc. purchased a new stake in shares of Prestige Consumer Healthcare during the second quarter worth approximately $9,832,000. Institutional investors and hedge funds own 99.95% of the company’s stock.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare, Inc is a leading manufacturer and marketer of branded over-the-counter (OTC) healthcare products. The company focuses on developing, acquiring and commercializing a diverse portfolio of non-prescription remedies designed to address common consumer health needs, including pain relief, cold and cough, digestive health, eye care, skin care and women’s health.

Key brands in Prestige’s portfolio include Clear Eyes (eye health), Carmex (lip care), Chloraseptic (sore throat relief), Dramamine (motion sickness), Rolaids (antacid), Monistat (women’s health), BC Powder (pain relief), Little Remedies (pediatric cold and gas relief) and TheraTears (dry eye therapy).